Publications by authors named "Laura Labonte"

Claim this Profile
U
Understanding loneliness: The roles of self- and interpersonal dysfunction and early parental indifference.
Laura E Labonté, David Kealy

Bull Menninger Clin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose intravenous hydromorphone for patients who use opioids in the hospital setting: time to reduce the barriers.
Laura E Labonté, Samantha Young

Harm Reduct J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.
Matthew J LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Laura R LaBonte

J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers.
Toshio Kawanami, Laura R LaBonte, Jakal Amin, Stefan J Thibodeaux, Cameron C Lee

Int J Pharm· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.
Jeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, Ying-Nan Chen, Homan Chan, Laura R LaBonte

J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.
Patrick Sarver, Michael Acker, Jeffrey T Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Laura R LaBonte

J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.
Patrick Sarver, Michael Acker, Jeffrey T Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Laura R LaBonte

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.
Jeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, Ying-Nan Chen, Homan Chan, Laura R LaBonte

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.
Riany de Sousa Sena, Sara Ahmed, Wan C Tan, Pei Z Li, Laura Labonté

Eur Respir J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor.
Jorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, Zhouliang Chen, Zhan Deng, Laura R LaBonte

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.
Laura E Labonté, Wan C Tan, Pei Z Li, Palmina Mancino, Shawn D Aaron

Am J Respir Crit Care Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.
Laura E Labonté, Jean Bourbeau, Stella S Daskalopoulou, Michele Zhang, Patrick Coulombe

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Evaluation of Wajima Superposition (Steady-State Concentration to Mean Residence Time) in the Estimation of Human Intravenous Pharmacokinetic Profile.
Franco Lombardo, Giuliano Berellini, Laura R Labonte, Guiqing Liang, Sean Kim

J Pharm Sci· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.
Laura Labonté, Patrick Coulombe, Michela Zago, Jean Bourbeau, Carolyn J Baglole

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct profile of vascular progenitor attachment to extracellular matrix proteins in cancer patients.
Laura Labonté, Yuhua Li, Christina L Addison, Marjorie Brand, Hedyeh Javidnia

Clin Invest Med· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
Laura Labonté, Yuhua Li, Lin Yang, Akira Gillingham, Michael Halpenny

Exp Hematol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
Gurnaam Kasbia, Farjah Al-Gahtani, Jason Tay, Laura Labonté, Alan Tinmouth

Transfusion· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma.
Laura Labonté, Tariq Iqbal, Mukarram A Zaidi, Sheryl A McDiarmid, Lothar B Huebsch

Biol Blood Marrow Transplant· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuing erythropoietin during peripheral blood stem cell collection in myeloma: can it reduce toxicity of autologous transplants?
Laura Labonté, Tariq Iqbal, Sheryl McDiarmid, Isabelle Bence-Bruckler, Lothar Huebsch

Biol Blood Marrow Transplant· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis